Tag: abt 199 clinical trials

BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis
Introduction: The prognostic worth of B-cell lymphoma 2 (BCL2) expression in de novo diffuse massive B-cell lymphoma (DLBCL) handled with immunochemotherapy is of curiosity to outline a goal affected person inhabitants for medical growth of BCL2 inhibitors. We aimed to develop a reproducible immunohistochemistry algorithm and assay to find out BCL2 protein expression and assess the…
Read More